Cargando…
High-Resolution Secretome Analysis of Chemical Hypoxia Treated Cells Identifies Putative Biomarkers of Chondrosarcoma
Chondrosarcoma is the second most common bone tumor, accounting for 20% of all cases. Little is known about the pathology and molecular mechanisms involved in the development and in the metastatic process of chondrosarcoma. As a consequence, there are no approved therapies for this tumor and surgica...
Autores principales: | Spanò, Donatella Pia, Bonelli, Simone, Calligaris, Matteo, Carreca, Anna Paola, Carcione, Claudia, Zito, Giovanni, Nicosia, Aldo, Rizzo, Sergio, Scilabra, Simone Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326515/ https://www.ncbi.nlm.nih.gov/pubmed/35893766 http://dx.doi.org/10.3390/proteomes10030025 |
Ejemplares similares
-
Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
por: Calligaris, Matteo, et al.
Publicado: (2021) -
Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding
por: Spanò, Donatella Pia, et al.
Publicado: (2022) -
Identification of membrane proteins regulated by ADAM15 by SUSPECS proteomics
por: Calligaris, Matteo, et al.
Publicado: (2023) -
Quantitative Proteomics Reveals Changes Induced by TIMP-3 on Cell Membrane Composition and Novel Metalloprotease Substrates
por: Carreca, Anna Paola, et al.
Publicado: (2021) -
Quantitative Proteomics Reveals That ADAM15 Can Have Proteolytic-Independent Functions in the Steady State
por: Yang, Chun-Yao, et al.
Publicado: (2022)